相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
Norio Tanaka et al.
HAEMATOLOGICA (2022)
A targeting delivery system for effective genome editing in leukemia cells to reverse malignancy
Xiao-He Ren et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas
Makoto Sugaya
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection
Silvia Spoerl et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
Herman D. Lim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer
Luca Filippi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Theranostics in Oncology-Thriving, Now More than Ever
Rudolf A. Werner et al.
DIAGNOSTICS (2021)
Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17
Anke Zhang et al.
THERANOSTICS (2021)
Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
Andrea Cimini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Radiation-Enhanced Expression of CCL22 in Nasopharyngeal Carcinoma is Associated With CCR4+ CD8 T Cell Recruitment
Hanghang Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer
Luca Filippi et al.
EXPERT REVIEW OF MEDICAL DEVICES (2020)
CCR4 Expression in Tumor-Infiltrating Regulatory T Cells in Patients with Squamous Cell Carcinoma of the Lung: A Prognostic Factor for Relapse and Survival
Nobuhiro Asai et al.
CANCER INVESTIGATION (2019)
Radionuclide- Labeled Peptides for Imaging and Treatment of CXCR4-Overexpressing Malignant Tumors
Nan Liu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
CCR4 Expression Is Associated With Poor Prognosis in Patients With Early Stage (pNO) Oral Tongue Cancer
Lei Wang et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2019)
The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides
Claudia Hossain et al.
CHINESE CLINICAL ONCOLOGY (2019)
Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma
Adriana T. Lopez et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
Clinical and epidemiological profile of patients with early stage mycosis fungoides
Gustavo Moreira Amorim et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2018)
Synthesis and evaluation of a 99mTc-labeled chemokine receptor antagonist peptide for imaging of chemokine receptor expressing tumors
Azadeh Mikaeili et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent
Margret Schottelius et al.
THERANOSTICS (2017)
Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior
Xi Cheng et al.
SCIENTIFIC REPORTS (2017)
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
Ken Herrmann et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer
Baochi Ou et al.
ONCOTARGET (2016)
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic et al.
BLOOD (2015)
Structural Characterization and in Vivo Evaluation of β-Hairpin Peptidomimetics as Specific CXCR4 Imaging Agents
Wojciech G. Lesniak et al.
MOLECULAR PHARMACEUTICS (2015)
CCR4 and its ligands: from bench to bedside
Osamu Yoshie et al.
INTERNATIONAL IMMUNOLOGY (2015)
A radiogallium-DOTA-based bivalent peptidic ligand targeting a chemokine receptor, CXCR4, for tumor imaging
Kohei Sano et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Rictor/mammalian target of rapamycin 2 regulates the development of notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3
Chunlan Hua et al.
EXPERIMENTAL HEMATOLOGY (2014)
Multicenter Phase II Study of Mogamulizumab ( KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Michinori Ogura et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma
Qiang Liu et al.
MEDICAL ONCOLOGY (2014)
Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppression
Yong-Mei Yang et al.
CANCER SCIENCE (2011)
Hybrid Peptide Dendrimers for Imaging of Chemokine Receptor 4 (CXCR4) Expression
Joeri Kuil et al.
MOLECULAR PHARMACEUTICS (2011)
Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease
Blythe D. Sather et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
CCR4-dependent regulatory T cell function in inflammatory bowel disease
Qian Yuan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors
Hirofumi Hanaoka et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor
I Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
分享论文
